Exploring the relationship between North Star Ambulatory Assessment and Health Utilities Index scores in Duchenne muscular dystrophy.
Duchenne muscular dystrophy
HUI
NSAA
Utility
Journal
Health and quality of life outcomes
ISSN: 1477-7525
Titre abrégé: Health Qual Life Outcomes
Pays: England
ID NLM: 101153626
Informations de publication
Date de publication:
19 Jul 2023
19 Jul 2023
Historique:
received:
31
03
2023
accepted:
07
07
2023
medline:
21
7
2023
pubmed:
20
7
2023
entrez:
19
7
2023
Statut:
epublish
Résumé
The North Star Ambulatory Assessment (NSAA) documents motor performance in ambulatory individuals with Duchenne muscular dystrophy (DMD). Health Utilities Index (HUI) scores, reflecting preferences for health-related quality-of-life (HRQoL) implications of health states, are commonly estimated within trials. This study sought to characterize the relationship between the NSAA score and utility in DMD. Family members serving as proxy respondents for placebo-treated ambulatory individuals with DMD (NCT01254019; BioMarin Pharmaceuticals Inc) completed the HUI and the NSAA (score range, 0-34). Mean change over time on these measures was estimated, and the correlation between changes in NSAA score and a) HUI utility; b) HUI3 ambulation and HUI2 mobility attribute scores, over 48 weeks was calculated. Baseline mean (range) age was 8.0 years (5-16; n = 61) and mean (standard deviation [SD]) scores were 0.87 (0.13; HUI2), 0.82 (0.19; HUI3), and 21.0 (8.1; NSAA). Mean (SD) change over 48 weeks was -0.05 (0.14; HUI2), -0.06 (0.19; HUI3), and -2.9 (4.7; NSAA). Weak positive correlations were observed between baseline NSAA score and HUI utility (HUI2: r = 0.29; HUI3: r = 0.17) and for change over 48 weeks (HUI2: r = 0.16; HUI3: r = 0.15). Stronger correlations were observed between change in NSAA score and the HUI3 ambulation (r = 0.41) and HUI2 mobility (r = 0.41) attributes. Among ambulatory individuals with DMD, NSAA score is weakly correlated with HUI utility, suggesting that motor performance alone does not fully explain HRQoL. Stronger relationships were observed between HUI ambulation and mobility attributes, and NSAA. Although unidimensional measures like the NSAA are informative for documenting disease-specific health impacts, they may not correlate well with measures of overall health status; requiring use in conjunction with other patient-reported and preference-based outcomes.
Sections du résumé
BACKGROUND
BACKGROUND
The North Star Ambulatory Assessment (NSAA) documents motor performance in ambulatory individuals with Duchenne muscular dystrophy (DMD). Health Utilities Index (HUI) scores, reflecting preferences for health-related quality-of-life (HRQoL) implications of health states, are commonly estimated within trials. This study sought to characterize the relationship between the NSAA score and utility in DMD.
METHODS
METHODS
Family members serving as proxy respondents for placebo-treated ambulatory individuals with DMD (NCT01254019; BioMarin Pharmaceuticals Inc) completed the HUI and the NSAA (score range, 0-34). Mean change over time on these measures was estimated, and the correlation between changes in NSAA score and a) HUI utility; b) HUI3 ambulation and HUI2 mobility attribute scores, over 48 weeks was calculated.
RESULTS
RESULTS
Baseline mean (range) age was 8.0 years (5-16; n = 61) and mean (standard deviation [SD]) scores were 0.87 (0.13; HUI2), 0.82 (0.19; HUI3), and 21.0 (8.1; NSAA). Mean (SD) change over 48 weeks was -0.05 (0.14; HUI2), -0.06 (0.19; HUI3), and -2.9 (4.7; NSAA). Weak positive correlations were observed between baseline NSAA score and HUI utility (HUI2: r = 0.29; HUI3: r = 0.17) and for change over 48 weeks (HUI2: r = 0.16; HUI3: r = 0.15). Stronger correlations were observed between change in NSAA score and the HUI3 ambulation (r = 0.41) and HUI2 mobility (r = 0.41) attributes.
CONCLUSIONS
CONCLUSIONS
Among ambulatory individuals with DMD, NSAA score is weakly correlated with HUI utility, suggesting that motor performance alone does not fully explain HRQoL. Stronger relationships were observed between HUI ambulation and mobility attributes, and NSAA. Although unidimensional measures like the NSAA are informative for documenting disease-specific health impacts, they may not correlate well with measures of overall health status; requiring use in conjunction with other patient-reported and preference-based outcomes.
Identifiants
pubmed: 37468890
doi: 10.1186/s12955-023-02160-8
pii: 10.1186/s12955-023-02160-8
pmc: PMC10355009
doi:
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
76Informations de copyright
© 2023. The Author(s).
Références
J Paediatr Child Health. 2015 Aug;51(8):759-64
pubmed: 25752877
Health Qual Life Outcomes. 2022 Jun 11;20(1):93
pubmed: 35690783
Neuromuscul Disord. 2019 Jul;29(7):514-516
pubmed: 31272741
Orphanet J Rare Dis. 2021 May 22;16(1):237
pubmed: 34022943
PLoS One. 2019 Sep 3;14(9):e0221097
pubmed: 31479456
PLoS One. 2014 Oct 01;9(10):e108205
pubmed: 25271887
Health Qual Life Outcomes. 2018 Dec 19;16(1):237
pubmed: 30567556
Physiother Res Int. 2012 Jun;17(2):101-9
pubmed: 21954141
Dev Med Child Neurol. 2016 May;58(5):508-15
pubmed: 26483095
Value Health. 2016 Sep - Oct;19(6):704-719
pubmed: 27712695
Neuromuscul Disord. 2010 Nov;20(11):712-6
pubmed: 20634072
Neuromuscul Disord. 2013 Jul;23(7):529-39
pubmed: 23726376
Qual Life Res. 2020 Mar;29(3):593-605
pubmed: 31811595
J Pediatr. 2014 Nov;165(5):1008-10
pubmed: 25149498
Pediatr Clin North Am. 2015 Jun;62(3):723-42
pubmed: 26022172
Pediatr Neurol. 2014 Jun;50(6):557-63
pubmed: 24842254
Neuromuscul Disord. 2009 Jul;19(7):458-61
pubmed: 19553120
Indian J Pediatr. 2022 Feb;89(2):113-117
pubmed: 34018133
Hum Mutat. 2018 Sep;39(9):1193-1202
pubmed: 29907980
Scand Cardiovasc J. 2022 Dec;56(1):310-315
pubmed: 35929855
Value Health. 2018 Feb;21(2):119-123
pubmed: 29477388
Dev Med Child Neurol. 2011 Jun;53(6):535-42
pubmed: 21410696
Neuromuscul Disord. 2021 Apr;31(4):328-335
pubmed: 33593658
Neuromuscul Disord. 2016 Mar;26(3):189-96
pubmed: 26916554
Value Health. 2021 Oct;24(10):1499-1510
pubmed: 34593174
Neurology. 2011 Jul 19;77(3):250-6
pubmed: 21734183
BMC Pulm Med. 2018 Jul 13;18(1):114
pubmed: 30005658
Health Qual Life Outcomes. 2003 Oct 16;1:54
pubmed: 14613568
Dev Med Child Neurol. 2013 Nov;55(11):1046-52
pubmed: 23909763
Neurology. 2014 Aug 5;83(6):529-36
pubmed: 24991029
Neurology. 2021 May 11;96(19):e2438-e2450
pubmed: 33785551